Dermabrasion for Acne Scars During Treatment with Oral Isotretinoin

BACKGROUND Oral isotretinoin is the criterion standard treatment for severe inflammatory acne associated with scar development. Atypical or exaggerated cicatrization related to oral isotretinoin was reported throughout the 1980s and 1990s. Dermabrasion for atrophic acne scar revision is not recommen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatologic surgery 2010-04, Vol.36 (4), p.483-489
Hauptverfasser: BAGATIN, EDILÉIA, DOS SANTOS GUADANHIM, LILIA RAMOS, YARAK, SAMIRA, KAMAMOTO, CRISTHINE SOUZA LEÃO, DE ALMEIDA, FERNANDO AUGUSTO
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 489
container_issue 4
container_start_page 483
container_title Dermatologic surgery
container_volume 36
creator BAGATIN, EDILÉIA
DOS SANTOS GUADANHIM, LILIA RAMOS
YARAK, SAMIRA
KAMAMOTO, CRISTHINE SOUZA LEÃO
DE ALMEIDA, FERNANDO AUGUSTO
description BACKGROUND Oral isotretinoin is the criterion standard treatment for severe inflammatory acne associated with scar development. Atypical or exaggerated cicatrization related to oral isotretinoin was reported throughout the 1980s and 1990s. Dermabrasion for atrophic acne scar revision is not recommended 6 to 12 months from the end of oral isotretinoin treatment. OBJECTIVE To evaluate wound healing after localized dermabrasion in patients receiving oral isotretinoin. MATERIALS & METHODS Interventional, prospective study involving seven patients taking oral isotretinoin to treat acne and with atrophic acne scars on the face. Manual dermabrasion was performed on all patients in an area of approximately 1 cm2, and a 6‐month reepithelization follow‐up by clinical evaluation was conducted. RESULTS All patients presented normal cicatrization evolution; hypertrophic scarring or keloid as a result of localized abrasion was not observed, and atrophic acne scar revision result was excellent. CONCLUSION The current recommendation to wait 6 to 12 months after treatment with oral isotretinoin for acne scar revision using dermabrasion should be re‐evaluated. Abrasion of a small test area may be a useful predictor of wound healing, enabling earlier acne scar treatment using this procedure. The authors have indicated no significant interest with commercial supporters.
doi_str_mv 10.1111/j.1524-4725.2010.01474.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733898629</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733898629</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3984-de5b77992d56451a0d7a4b378320fa58ae27db949ee0628654aae9bec55171793</originalsourceid><addsrcrecordid>eNqNkD1v2zAQhomgRZ24_QsFl6KTXH6K5NAhsJM0QIAMTmbiJJ1SGvpISRm2_32k2HXXcuGB97zHw0MI5WzBx_Njs-BaqEwZoReCja-MK6MW-wtyeW58GGtm8oxpLmbkKqUNY1w4yT6R2ZixzMr8kixXGFsoIqTQd7TuI70uO6TrEmKiq20M3Qt9ighDi91Ad2H4TR8jNPQ-9UPEIXR96D6TjzU0Cb-c7jl5vr15Wv7KHh7v7pfXD1kpnVVZhbowxjlR6VxpDqwyoApprBSsBm0BhakKpxwiy4XNtQJAV2CpNTfcODkn349zX2P_Z4tp8G1IJTYNdNhvkzdSWmdzMZH2SJaxTyli7V9jaCEePGd-Mug3fhLlJ1F-MujfDfr9GP16-mRbtFidg3-VjcC3EwCphKaO0JUh_eOE0UIyOXI_j9wuNHj47wX8av08VfINVVKKug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733898629</pqid></control><display><type>article</type><title>Dermabrasion for Acne Scars During Treatment with Oral Isotretinoin</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Journals@Ovid Complete</source><creator>BAGATIN, EDILÉIA ; DOS SANTOS GUADANHIM, LILIA RAMOS ; YARAK, SAMIRA ; KAMAMOTO, CRISTHINE SOUZA LEÃO ; DE ALMEIDA, FERNANDO AUGUSTO</creator><creatorcontrib>BAGATIN, EDILÉIA ; DOS SANTOS GUADANHIM, LILIA RAMOS ; YARAK, SAMIRA ; KAMAMOTO, CRISTHINE SOUZA LEÃO ; DE ALMEIDA, FERNANDO AUGUSTO</creatorcontrib><description>BACKGROUND Oral isotretinoin is the criterion standard treatment for severe inflammatory acne associated with scar development. Atypical or exaggerated cicatrization related to oral isotretinoin was reported throughout the 1980s and 1990s. Dermabrasion for atrophic acne scar revision is not recommended 6 to 12 months from the end of oral isotretinoin treatment. OBJECTIVE To evaluate wound healing after localized dermabrasion in patients receiving oral isotretinoin. MATERIALS &amp; METHODS Interventional, prospective study involving seven patients taking oral isotretinoin to treat acne and with atrophic acne scars on the face. Manual dermabrasion was performed on all patients in an area of approximately 1 cm2, and a 6‐month reepithelization follow‐up by clinical evaluation was conducted. RESULTS All patients presented normal cicatrization evolution; hypertrophic scarring or keloid as a result of localized abrasion was not observed, and atrophic acne scar revision result was excellent. CONCLUSION The current recommendation to wait 6 to 12 months after treatment with oral isotretinoin for acne scar revision using dermabrasion should be re‐evaluated. Abrasion of a small test area may be a useful predictor of wound healing, enabling earlier acne scar treatment using this procedure. The authors have indicated no significant interest with commercial supporters.</description><identifier>ISSN: 1076-0512</identifier><identifier>EISSN: 1524-4725</identifier><identifier>DOI: 10.1111/j.1524-4725.2010.01474.x</identifier><identifier>PMID: 20180836</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Acne Keloid - etiology ; Acne Keloid - surgery ; Acne Vulgaris - complications ; Acne Vulgaris - drug therapy ; Administration, Oral ; Adolescent ; Adult ; Biological and medical sciences ; Cicatrix, Hypertrophic - etiology ; Cicatrix, Hypertrophic - surgery ; Combined Modality Therapy ; Dermabrasion - methods ; Dermatologic Agents - administration &amp; dosage ; Dermatology ; Face ; Female ; Humans ; Isotretinoin - administration &amp; dosage ; Isotretinoin - adverse effects ; Male ; Medical sciences ; Patient Satisfaction ; Prospective Studies ; Skin involvement in other diseases. Miscellaneous. General aspects ; Skin plastic surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Treatment Outcome ; Wound Healing ; Young Adult</subject><ispartof>Dermatologic surgery, 2010-04, Vol.36 (4), p.483-489</ispartof><rights>2010 by the American Society for Dermatologic Surgery, Inc.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3984-de5b77992d56451a0d7a4b378320fa58ae27db949ee0628654aae9bec55171793</citedby><cites>FETCH-LOGICAL-c3984-de5b77992d56451a0d7a4b378320fa58ae27db949ee0628654aae9bec55171793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1524-4725.2010.01474.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1524-4725.2010.01474.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22752303$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20180836$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BAGATIN, EDILÉIA</creatorcontrib><creatorcontrib>DOS SANTOS GUADANHIM, LILIA RAMOS</creatorcontrib><creatorcontrib>YARAK, SAMIRA</creatorcontrib><creatorcontrib>KAMAMOTO, CRISTHINE SOUZA LEÃO</creatorcontrib><creatorcontrib>DE ALMEIDA, FERNANDO AUGUSTO</creatorcontrib><title>Dermabrasion for Acne Scars During Treatment with Oral Isotretinoin</title><title>Dermatologic surgery</title><addtitle>Dermatol Surg</addtitle><description>BACKGROUND Oral isotretinoin is the criterion standard treatment for severe inflammatory acne associated with scar development. Atypical or exaggerated cicatrization related to oral isotretinoin was reported throughout the 1980s and 1990s. Dermabrasion for atrophic acne scar revision is not recommended 6 to 12 months from the end of oral isotretinoin treatment. OBJECTIVE To evaluate wound healing after localized dermabrasion in patients receiving oral isotretinoin. MATERIALS &amp; METHODS Interventional, prospective study involving seven patients taking oral isotretinoin to treat acne and with atrophic acne scars on the face. Manual dermabrasion was performed on all patients in an area of approximately 1 cm2, and a 6‐month reepithelization follow‐up by clinical evaluation was conducted. RESULTS All patients presented normal cicatrization evolution; hypertrophic scarring or keloid as a result of localized abrasion was not observed, and atrophic acne scar revision result was excellent. CONCLUSION The current recommendation to wait 6 to 12 months after treatment with oral isotretinoin for acne scar revision using dermabrasion should be re‐evaluated. Abrasion of a small test area may be a useful predictor of wound healing, enabling earlier acne scar treatment using this procedure. The authors have indicated no significant interest with commercial supporters.</description><subject>Acne Keloid - etiology</subject><subject>Acne Keloid - surgery</subject><subject>Acne Vulgaris - complications</subject><subject>Acne Vulgaris - drug therapy</subject><subject>Administration, Oral</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Cicatrix, Hypertrophic - etiology</subject><subject>Cicatrix, Hypertrophic - surgery</subject><subject>Combined Modality Therapy</subject><subject>Dermabrasion - methods</subject><subject>Dermatologic Agents - administration &amp; dosage</subject><subject>Dermatology</subject><subject>Face</subject><subject>Female</subject><subject>Humans</subject><subject>Isotretinoin - administration &amp; dosage</subject><subject>Isotretinoin - adverse effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Patient Satisfaction</subject><subject>Prospective Studies</subject><subject>Skin involvement in other diseases. Miscellaneous. General aspects</subject><subject>Skin plastic surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Treatment Outcome</subject><subject>Wound Healing</subject><subject>Young Adult</subject><issn>1076-0512</issn><issn>1524-4725</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkD1v2zAQhomgRZ24_QsFl6KTXH6K5NAhsJM0QIAMTmbiJJ1SGvpISRm2_32k2HXXcuGB97zHw0MI5WzBx_Njs-BaqEwZoReCja-MK6MW-wtyeW58GGtm8oxpLmbkKqUNY1w4yT6R2ZixzMr8kixXGFsoIqTQd7TuI70uO6TrEmKiq20M3Qt9ighDi91Ad2H4TR8jNPQ-9UPEIXR96D6TjzU0Cb-c7jl5vr15Wv7KHh7v7pfXD1kpnVVZhbowxjlR6VxpDqwyoApprBSsBm0BhakKpxwiy4XNtQJAV2CpNTfcODkn349zX2P_Z4tp8G1IJTYNdNhvkzdSWmdzMZH2SJaxTyli7V9jaCEePGd-Mug3fhLlJ1F-MujfDfr9GP16-mRbtFidg3-VjcC3EwCphKaO0JUh_eOE0UIyOXI_j9wuNHj47wX8av08VfINVVKKug</recordid><startdate>201004</startdate><enddate>201004</enddate><creator>BAGATIN, EDILÉIA</creator><creator>DOS SANTOS GUADANHIM, LILIA RAMOS</creator><creator>YARAK, SAMIRA</creator><creator>KAMAMOTO, CRISTHINE SOUZA LEÃO</creator><creator>DE ALMEIDA, FERNANDO AUGUSTO</creator><general>Blackwell Publishing Inc</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201004</creationdate><title>Dermabrasion for Acne Scars During Treatment with Oral Isotretinoin</title><author>BAGATIN, EDILÉIA ; DOS SANTOS GUADANHIM, LILIA RAMOS ; YARAK, SAMIRA ; KAMAMOTO, CRISTHINE SOUZA LEÃO ; DE ALMEIDA, FERNANDO AUGUSTO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3984-de5b77992d56451a0d7a4b378320fa58ae27db949ee0628654aae9bec55171793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Acne Keloid - etiology</topic><topic>Acne Keloid - surgery</topic><topic>Acne Vulgaris - complications</topic><topic>Acne Vulgaris - drug therapy</topic><topic>Administration, Oral</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Cicatrix, Hypertrophic - etiology</topic><topic>Cicatrix, Hypertrophic - surgery</topic><topic>Combined Modality Therapy</topic><topic>Dermabrasion - methods</topic><topic>Dermatologic Agents - administration &amp; dosage</topic><topic>Dermatology</topic><topic>Face</topic><topic>Female</topic><topic>Humans</topic><topic>Isotretinoin - administration &amp; dosage</topic><topic>Isotretinoin - adverse effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Patient Satisfaction</topic><topic>Prospective Studies</topic><topic>Skin involvement in other diseases. Miscellaneous. General aspects</topic><topic>Skin plastic surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Treatment Outcome</topic><topic>Wound Healing</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BAGATIN, EDILÉIA</creatorcontrib><creatorcontrib>DOS SANTOS GUADANHIM, LILIA RAMOS</creatorcontrib><creatorcontrib>YARAK, SAMIRA</creatorcontrib><creatorcontrib>KAMAMOTO, CRISTHINE SOUZA LEÃO</creatorcontrib><creatorcontrib>DE ALMEIDA, FERNANDO AUGUSTO</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Dermatologic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BAGATIN, EDILÉIA</au><au>DOS SANTOS GUADANHIM, LILIA RAMOS</au><au>YARAK, SAMIRA</au><au>KAMAMOTO, CRISTHINE SOUZA LEÃO</au><au>DE ALMEIDA, FERNANDO AUGUSTO</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dermabrasion for Acne Scars During Treatment with Oral Isotretinoin</atitle><jtitle>Dermatologic surgery</jtitle><addtitle>Dermatol Surg</addtitle><date>2010-04</date><risdate>2010</risdate><volume>36</volume><issue>4</issue><spage>483</spage><epage>489</epage><pages>483-489</pages><issn>1076-0512</issn><eissn>1524-4725</eissn><abstract>BACKGROUND Oral isotretinoin is the criterion standard treatment for severe inflammatory acne associated with scar development. Atypical or exaggerated cicatrization related to oral isotretinoin was reported throughout the 1980s and 1990s. Dermabrasion for atrophic acne scar revision is not recommended 6 to 12 months from the end of oral isotretinoin treatment. OBJECTIVE To evaluate wound healing after localized dermabrasion in patients receiving oral isotretinoin. MATERIALS &amp; METHODS Interventional, prospective study involving seven patients taking oral isotretinoin to treat acne and with atrophic acne scars on the face. Manual dermabrasion was performed on all patients in an area of approximately 1 cm2, and a 6‐month reepithelization follow‐up by clinical evaluation was conducted. RESULTS All patients presented normal cicatrization evolution; hypertrophic scarring or keloid as a result of localized abrasion was not observed, and atrophic acne scar revision result was excellent. CONCLUSION The current recommendation to wait 6 to 12 months after treatment with oral isotretinoin for acne scar revision using dermabrasion should be re‐evaluated. Abrasion of a small test area may be a useful predictor of wound healing, enabling earlier acne scar treatment using this procedure. The authors have indicated no significant interest with commercial supporters.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>20180836</pmid><doi>10.1111/j.1524-4725.2010.01474.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1076-0512
ispartof Dermatologic surgery, 2010-04, Vol.36 (4), p.483-489
issn 1076-0512
1524-4725
language eng
recordid cdi_proquest_miscellaneous_733898629
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Journals@Ovid Complete
subjects Acne Keloid - etiology
Acne Keloid - surgery
Acne Vulgaris - complications
Acne Vulgaris - drug therapy
Administration, Oral
Adolescent
Adult
Biological and medical sciences
Cicatrix, Hypertrophic - etiology
Cicatrix, Hypertrophic - surgery
Combined Modality Therapy
Dermabrasion - methods
Dermatologic Agents - administration & dosage
Dermatology
Face
Female
Humans
Isotretinoin - administration & dosage
Isotretinoin - adverse effects
Male
Medical sciences
Patient Satisfaction
Prospective Studies
Skin involvement in other diseases. Miscellaneous. General aspects
Skin plastic surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Treatment Outcome
Wound Healing
Young Adult
title Dermabrasion for Acne Scars During Treatment with Oral Isotretinoin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T04%3A24%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dermabrasion%20for%20Acne%20Scars%20During%20Treatment%20with%20Oral%20Isotretinoin&rft.jtitle=Dermatologic%20surgery&rft.au=BAGATIN,%20EDIL%C3%89IA&rft.date=2010-04&rft.volume=36&rft.issue=4&rft.spage=483&rft.epage=489&rft.pages=483-489&rft.issn=1076-0512&rft.eissn=1524-4725&rft_id=info:doi/10.1111/j.1524-4725.2010.01474.x&rft_dat=%3Cproquest_cross%3E733898629%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733898629&rft_id=info:pmid/20180836&rfr_iscdi=true